Endogenous and exogenous ligands of aryl hydrocarbon receptor: Current state of art

Current Drug Metabolism

Volumn 12, Issue 2, 2011, Pages 198-212

  Stejskalova, Lucie ^a   Dvorak, Zdenek ^b   Pavek, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Aryl hydrocarbon receptor; Dietary ligands; Ligand dependent activation; Natural compounds; Synthetic ligands; Xenobiotics

Indexed keywords

1,3,8 TRICHLORO 6 METHYLDIBENZOFURAN; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 METHYL 2H PYRAZOLE 3 CARBOXYLIC ACID (2 METHYL 4 O TOLYLAZO PHENYL)AMIDE; 3 [(2,4 DIMETHYLPYRROL 5 YL)METHYLIDENYL] 2 INDOLINONE; 3 [2 (2 PHENYLETHYL)BENZOIMIDAZOLE 4 YL] 3 HYDROXYPROPANOIC ACID; 3 METHOXY 4' NITROFLAVONE; 6,2',4' TRIMETHOXYFLAVONE; [4 (3 CHLORO PHENYL) PYRIMIDIN 2 YL] (4 TRIFLUOROMETHYL PHENYL)AMINE; ALPHA NAPHTHOFLAVONE; AMIDE; AMINE; ANGIOGENESIS INHIBITOR; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; AROMATIC HYDROCARBON RECEPTOR; BENZENE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; BENZO[A]PYRENE DERIVATIVE; BETA NAPHTHOFLAVONE; CH 223191; DIBENZOFURAN DERIVATIVE; DIOXIN; ETHYL 3 HYDROXY 3 [2 (2 PHENYLETHYL)BENZOIMIDAZOL 4 YL]PROPANOATE; FLAVONE DERIVATIVE; M 50354; M 50367; NAPHTHALENE DERIVATIVE; OMEPRAZOLE; POLYCHLORINATED BIPHENYL DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; PRIMAQUINE; PROPIONIC ACID DERIVATIVE; TSU 16; UNCLASSIFIED DRUG; UNINDEXED DRUG; VAF 347;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; DRUG ANTAGONISM; DRUG POTENCY; DRUG STRUCTURE; GENE EXPRESSION; GENE MUTATION; HUMAN; LIGAND BINDING; NONHUMAN;

ANIMALS; HUMANS; LIGANDS; MOLECULAR STRUCTURE; RECEPTORS, ARYL HYDROCARBON; XENOBIOTICS;

EID: 79952792921     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920011795016818     Document Type: Article

References (167)

1. Puga, A.; Ma, C.; Marlowe, J. L. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem. Pharmacol., 2009, 77(4), 713-22.
2. Marlowe, J. L.; Puga, A. Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis, J. Cell. Biochem., 2005, 96(6), 1174-84. (Pubitemid 41681860)
3. Bock, K. W.; Kohle, C. Ah receptor- and TCDD-mediated liver tumor promotion: Clonal selection and expansion of cells evading growth arrest and apoptosis. Biochem. Pharmacol., 2005, 69(10), 1403-8. (Pubitemid 40602440)
4. Esser, C. The immune phenotype of AhR null mouse mutants: Not a simple mirror of xenobiotic receptor over-activation. Biochem. Pharmacol., 2009, 77(4), 597-607.
5. Esser, C.; Rannug, A.; Stockinger, B. The aryl hydrocarbon receptor in immunity. Trends Immunol., 2009, 30(9), 447-54.
6. Head, J. L.; Lawrence, B. P. The aryl hydrocarbon receptor is a modulator of anti-viral immunity. Biochem. Pharmacol., 2009, 77(4), 642-53.
7. Shimba, S.; Watabe, Y. Crosstalk between the AHR signaling pathway and circadian rhythm. Biochem. Pharmacol., 2009, 77(4), 560-5.
8. Gasiewicz, T. A.; Henry, E. C.; Collins, L. L. Expression and activity of aryl hydrocarbon receptors in development and cancer. Crit. Rev. Eukaryot. Gene Expr., 2008, 18(4), 279-321. (Pubitemid 351991362)
9. Ray, S.; Swanson, H. I. Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: A tumor promoting event?. Biochem. Pharmacol., 2009, 77(4), 681-8.
10. Gouedard, C.; Barouki, R.; Morel, Y. Induction of the paraoxonase- 1 gene expression by resveratrol. Arterioscler. Thromb. Vasc. Biol., 2004, 24(12), 2378-83. (Pubitemid 39658045)
11. Gouedard, C.; Barouki, R.; Morel, Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptordependent mechanism. Mol. Cell Biol., 2004, 24(12), 5209-22. (Pubitemid 38738157)
12. Micka, J.; Milatovich, A.; Menon, A.; Grabowski, G. A.; Puga, A.; Nebert, D. W. Human Ah receptor (AHR) gene: Localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibility. Pharmacogenetics, 1997, 7(2), 95-101. (Pubitemid 27261841)
13. Bennett, P.; Ramsden, D. B.; Williams, A. C. Complete structural characterisation of the human aryl hydrocarbon receptor gene. Clin. Mol. Pathol., 1996, 49(1), M12-M16.
14. Dolwick, K. M.; Schmidt, J. V.; Carver, L. A.; Swanson, H. I.; Bradfield, C. A. Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol., 1993, 44(5), 911-7. (Pubitemid 23344955)
15. Henklova, P.; Vrzal, R.; Ulrichova, J.; Dvorak, Z. Role of mitogenactivated protein kinases in aryl hydrocarbon receptor signaling. Chem. Biol. Interact., 2008, 172(2), 93-104.
16. McGuire, J.; Whitelaw, M. L.; Pongratz, I.; Gustafsson, J. A.; Poellinger, L. A cellular factor stimulates ligand-dependent release of hsp90 from the basic helix-loop-helix dioxin receptor. Mol. Cell Biol., 1994, 14(4), 2438-46. (Pubitemid 24108226)
17. Lees, M. J.; Whitelaw, M. L. Multiple roles of ligand in transforming the dioxin receptor to an active basic helix-loop-helix/PAS transcription factor complex with the nuclear protein Arnt. Mol. Cell Biol., 1999, 19(8), 5811-22. (Pubitemid 29339935)
18. Heid, S. E.; Pollenz, R. S.; Swanson, H. I. Role of heat shock protein 90 dissociation in mediating agonist-induced activation of the aryl hydrocarbon receptor. Mol. Pharmacol., 2000, 57(1), 82-92. (Pubitemid 30033263)
19. Pollenz, R. S.; Sattler, C. A.; Poland, A. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol. Pharmacol., 1994, 45(3), 428-38. (Pubitemid 24094931)
20. Pavek, P.; Dvorak, Z. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr. Drug Metab., 2008, 9(2), 129-43. (Pubitemid 351461002)
21. Pollenz, R. S. Specific blockage of ligand-induced degradation of the Ah receptor by proteasome but not calpain inhibitors in cell cul ture lines from different species. Biochem. Pharmacol., 2007, 74(1), 131-43. (Pubitemid 46802490)
22. Pollenz, R. S.; Buggy, C. Ligand-dependent and -independent degradation of the human aryl hydrocarbon receptor (hAHR) in cell culture models. Chem. Biol. Interact., 2006, 164(1-2), 49-59. (Pubitemid 44709710)
23. Pollenz, R. S.; Popat, J.; Dougherty, E. J. Role of the carboxyterminal transactivation domain and active transcription in the ligand-induced and ligand-independent degradation of the mouse Ahb-1 receptor. Biochem. Pharmacol., 2005, 70(11), 1623-33. (Pubitemid 41540355)
24. Poland, A.; Glover, E.; Kende, A. S. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem., 1976, 251(16), 4936-46.
25. Greenlee, W. F.; Poland, A. Nuclear uptake of 2,3,7,8- tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. Role of the hepatic cytosol receptor protein. J. Biol. Chem., 1979, 254(19), 9814-21. (Pubitemid 10107133)
26. Yamamoto, J.; Ihara, K.; Nakayama, H.; Hikino, S.; Satoh, K.; Kubo, N.; Iida, T.; Fujii, Y.; Hara, T. Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: Organspecific distribution and variable induction patterns in mononuclear cells. Life Sci., 2004, 74(8), 1039-49. (Pubitemid 37522137)
27. Hayashi, S.; Watanabe, J.; Nakachi, K.; Eguchi, H.; Gotoh, O.; Kawajiri, K. Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis, 1994, 15(5), 801-6. (Pubitemid 24156872)
28. Manchester, D. K.; Gordon, S. K.; Golas, C. L.; Roberts, E. A.; Okey, A. B. Ah receptor in human placenta: Stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo- p-dioxin, 3-methylcholanthrene, and benzo(a)pyrene. Cancer Res., 1987, 47(18), 4861-8. (Pubitemid 17143032)
29. Reisz-Porszasz, S.; Probst, M. R.; Fukunaga, B. N.; Hankinson, O. Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT). Mol. Cell Biol., 1994, 14(9), 6075-86. (Pubitemid 24264437)
30. Fukunaga, B. N.; Probst, M. R.; Reisz-Porszasz, S.; Hankinson, O. Identification of functional domains of the aryl hydrocarbon receptor. J. Biol. Chem., 1995, 270(49), 29270-8.
31. Jones, S. An overview of the basic helix-loop-helix proteins. Genome Biol., 2004, 5(6), 226.
32. Coumailleau, P.; Poellinger, L.; Gustafsson, J. A.; Whitelaw, M. L. Definition of a minimal domain of the dioxin receptor that is associated with Hsp90 and maintains wild type ligand binding affinity and specificity. J. Biol. Chem., 1995, 270(42), 25291-300.
33. Pandini, A.; Denison, M. S.; Song, Y.; Soshilov, A. A.; Bonati, L. Structural and functional characterization of the aryl hydrocarbon receptor ligand binding domain by homology modeling and mutational analysis. Biochemistry, 2007, 46(3), 696-708. (Pubitemid 46133587)
34. Goryo, K.; Suzuki, A.; Del Carpio, C. A.; Siizaki, K.; Kuriyama, E.; Mikami, Y.; Kinoshita, K.; Yasumoto, K.; Rannug, A.; Miyamoto, A.; Fujii-Kuriyama, Y.; Sogawa, K. Identification of amino acid residues in the Ah receptor involved in ligand binding. Biochem. Biophys. Res. Commun., 2007, 354(2), 396-402. (Pubitemid 46161339)
35. Ema, M.; Ohe, N.; Suzuki, M.; Mimura, J.; Sogawa, K.; Ikawa, S.; Fujii-Kuriyama, Y. Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. J. Biol. Chem., 1994, 269(44), 27337-43. (Pubitemid 24346556)
36. Leff, P. Inverse agonism: Theory and practice. Trends Pharmacol. Sci., 1995, 16(8), 256.
37. Leff, P. The two-state model of receptor activation. Trends Pharmacol. Sci., 1995, 16(3), 89-97.
38. Carlier, P. R.; Chow, E. S.; Barlow, R. L.; Bloomquist, J. R. Discovery of non-zwitterionic GABA(A) receptor full agonists and a superagonist. Bioorg. Med. Chem. Lett., 2002, 12(15), 1985-8. (Pubitemid 34756464)
39. Nguyen, L. P.; Bradfield, C. A. The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol., 2008, 21(1), 102-16. (Pubitemid 351219712)
40. Bohonowych, J. E.; Denison, M. S. Persistent binding of ligands to the aryl hydrocarbon receptor. Toxicol. Sci., 2007, 98(1), 99-109. (Pubitemid 47073824)
41. Chen, G.; Bunce, N. J. Interaction between halogenated aromatic compounds in the Ah receptor signal transduction pathway. Environ. Toxicol., 2004, 19(5), 480-9. (Pubitemid 39419627)
42. Franco, S. S.; Nardocci, A. C.; Gunther, W. M. PAH biomarkers for human health risk assessment: A review of the state-of-the-art. Cad. Saude. Publica., 2008, 24 (Suppl 4), s569-80.
43. Haritash, A. K.; Kaushik, C. P. Biodegradation aspects of polycyclic aromatic hydrocarbons (PAHs): A review. J. Hazard Mater., 2009, 169(1-3), 1-15.
44. Simko, P. Determination of polycyclic aromatic hydrocarbons in smoked meat products and smoke flavouring food additives. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 2002, 770(1-2), 3-18. (Pubitemid 34266833)
45. Baird, W. M.; Hooven, L. A.; Mahadevan, B. Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ. Mol. Mutagen, 2005, 45(2-3), 106-14.
46. Shimada, T.; Guengerich, F. P. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons. Chem. Res. Toxicol., 2006, 19(2), 288-94.
47. Wang, S.; Chanock, S.; Tang, D.; Li, Z.; Jedrychowski, W.; Perera, F. P. Assessment of interactions between PAH exposure and genetic polymorphisms on PAH-DNA adducts in African American, Dominican, and Caucasian mothers and newborns. Cancer Epidemiol. Biomarkers. Prev., 2008, 17(2), 405-13. (Pubitemid 351272794)
48. Slaga, T. J.; Jecker, L.; Bracken, W. M.; Weeks, C. E. The effects of weak or non-carcinogenic polycyclic hydrocarbons on 7, 12- dimethylbenz [a]anthracene and benzo [a]pyrene skin tumorinitiation. Cancer Lett., 1979, 7(1), 51-9. (Pubitemid 9193760)
49. Rubin, H. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: A bio-historical perspective with updates. Carcinogenesis, 2001, 22(12), 1903-30. (Pubitemid 34065385)
50. Shimada, T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab. Pharmacokinet., 2006, 21(4), 257-76.
51. Cavalieri, E. L.; Rogan, E. G. The approach to understanding aromatic hydrocarbon carcinogenesis. The central role of radical cations in metabolic activation. Pharmacol. Ther., 1992, 55(2), 183-99. (Pubitemid 23031372)
52. Rhim, J. S. Neoplastic transformation of human cells in vitro. Crit. Rev. Oncog., 1993, 4(3), 313-35.
53. Lutz, C. T.; Browne, G.; Petzold, C. R. Methylcholanthrene causes increased thymocyte apoptosis. Toxicology, 1998, 128(2), 151-67. (Pubitemid 28362971)
54. Safe, S. 3-methylcholanthrene induces differential recruitment of aryl hydrocarbon receptor to human promoters. Toxicol. Sci., 2010, 117(1), 1-3.
55. La Rocca, C.; Mantovani, A. From environment to food: The case of PCB. Ann. Ist. Super Sanita., 2006, 42(4), 410-6.
56. Safe, S.; Bandiera, S.; Sawyer, T.; Robertson, L.; Safe, L.; Parkinson, A.; Thomas, P. E.; Ryan, D. E.; Reik, L. M.; Levin, W. PCBs: Structure-function relationships and mechanism of action. Environ. Health Perspect., 1985, 60, 47-56. (Pubitemid 15038884)
57. Safe, S. Toxicology, structure-function relationship, and human and environmental health impacts of polychlorinated biphenyls: Progress and problems. Environ. Health Perspect., 1993, 100, 259-68. (Pubitemid 23197104)
58. Vickers, A. E.; Sloop, T. C.; Lucier, G. W. Mechanism of action of toxic halogenated aromatics. Environ. Health Perspect., 1985, 59, 121-8. (Pubitemid 15101717)
59. Hayes, K. R.; Zastrow, G. M.; Nukaya, M.; Pande, K.; Glover, E.; Maufort, J. P.; Liss, A. L.; Liu, Y.; Moran, S. M.; Vollrath, A. L.; Bradfield, C. A. Hepatic transcriptional networks induced by exposure to 2,3,7,8- tetrachlorodibenzo-p-dioxin, Chem. Res. Toxicol., 2007, 20(11), 1573-81. (Pubitemid 350275602)
60. Safe, S. Development of bioassays and approaches for the risk assessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Environ. Health Perspect., 1993, 101 (Suppl 3), 317-25. (Pubitemid 24014798)
61. Denison, M. S.; Heath-Pagliuso, S. The Ah receptor: A regulator of the biochemical and toxicological actions of structurally diverse chemicals. Bull. Environ. Contam. Toxicol., 1998, 61(5), 557-68. (Pubitemid 29010859)
62. Lesca, P.; Peryt, B.; Larrieu, G.; Alvinerie, M.; Galtier, P.; Daujat, M.; Maurel, P.; Hoogenboom, L. Evidence for the ligandindependent activation of the AH receptor. Biochem. Biophys. Res. Commun., 1995, 209(2), 474-82.
63. Shi, S.; Klotz, U. Proton pump inhibitors: An update of their clinical use and pharmacokinetics. Eur. J. Clin. Pharmacol., 2008, 64(10), 935-51.
64. Daujat, M.; Peryt, B.; Lesca, P.; Fourtanier, G.; Domergue, J.; Maurel, P. Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor. Biochem. Biophys. Res. Commun., 1992, 188(2), 820-5.
65. Murray, I. A.; Perdew, G. H. Omeprazole stimulates the induction of human insulin-like growth factor binding protein-1 through aryl hydrocarbon receptor activation. J. Pharmacol. Exp. Ther., 2008, 324(3), 1102-10. (Pubitemid 351397862)
66. Yoshinari, K.; Ueda, R.; Kusano, K.; Yoshimura, T.; Nagata, K.; Yamazoe, Y. Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements. Biochem. Pharmacol., 2008, 76(1), 139-45.
67. Gerbal-Chaloin, S.; Pichard-Garcia, L.; Fabre, J. M.; Sa-Cunha, A.; Poellinger, L.; Maurel, P.; Daujat-Chavanieu, M. Role of CYP3A4 in the regulation of the aryl hydrocarbon receptor by omeprazole sulphide. Cell Signal, 2006, 18(5), 740-50. (Pubitemid 43113303)
68. Curi-Pedrosa, R.; Daujat, M.; Pichard, L.; Ourlin, J. C.; Clair, P.; Gervot, L.; Lesca, P.; Domergue, J.; Joyeux, H.; Fourtanier, G. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. J. Pharmacol. Exp. Ther., 1994, 269(1), 384-92. (Pubitemid 24143278)
69. Bapiro, T. E.; Andersson, T. B.; Otter, C.; Hasler, J. A.; Masimirembwa, C. M. Cytochrome P450 1A1/2 induction by antiparasitic drugs: Dose-dependent increase in ethoxyresorufin Odeethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells. Eur. J. Clin. Pharmacol., 2002, 58(8), 537-42. (Pubitemid 35439154)
70. Basso, L. G.; Rodrigues, R. Z.; Naal, R. M.; Costa-Filho, A. J. Effects of the antimalarial drug primaquine on the dynamic structure of lipid model membranes. Biochim. Biophys. Acta, 2010, 1808(1), 55-64.
71. Fontaine, F.; Delescluse, C.; de Sousa, G.; Lesca, P.; Rahmani, R. Cytochrome 1A1 induction by primaquine in human hepatocytes and HepG2 cells: Absence of binding to the aryl hydrocarbon receptor. Biochem. Pharmacol., 1999, 57(3), 255-62. (Pubitemid 29056203)
72. Werlinder, V.; Backlund, M.; Zhukov, A.; Ingelman-Sundberg, M. Transcriptional and post-translational regulation of CYP1A1 by primaquine. J. Pharmacol. Exp. Ther., 2001, 297(1), 206-14. (Pubitemid 32242580)
73. Reiners, J. J., Jr.; Lee, J. Y.; Clift, R. E.; Dudley, D. T.; Myrand, S. P. PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase. Mol. Pharmacol., 1998, 53(3), 438-45. (Pubitemid 28162865)
74. Andrieux, L.; Langouet, S.; Fautrel, A.; Ezan, F.; Krauser, J. A.; Savouret, J. F.; Guengerich, F. P.; Baffet, G.; Guillouzo, A. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes. Mol. Pharmacol., 2004, 65(4), 934-43. (Pubitemid 38420499)
75. Dvorak, Z.; Vrzal, R.; Henklova, P.; Jancova, P.; Anzenbacherova, E.; Maurel, P.; Svecova, L.; Pavek, P.; Ehrmann, J.; Havlik, R.; Bednar, P.; Lemr, K.; Ulrichova, J. JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes. Biochem. Pharmacol., 2008, 75(2), 580-8. (Pubitemid 350298475)
76. Matsuoka-Kawano, K.; Yoshinari, K.; Nagayama, S.; Yamazoe, Y. TSU-16, (Z)-3- [(2,4-dimethylpyrrol-5-yl)methylidenyl]-2-indolinone, is a potent activator of aryl hydrocarbon receptor and increases CYP1A1 and CYP1A2 expression in human hepatocytes. Chem. Biol. Interact., 2010, 185(1), 33-41.
77. Bachleda, P.; Dvorak, Z. Pharmacological inhibitors of JNK and ERK kinases SP600125 and U0126 are not appropriate tools for studies of drug metabolism because they activate aryl hydrocarbon receptor. Gen. Physiol. Biophys., 2008, 27(2), 143-5.
78. Joiakim, A.; Mathieu, P. A.; Palermo, C.; Gasiewicz, T. A.; Reiners, J. J., Jr. The Jun N-terminal kinase inhibitor SP600125 is a ligand and antagonist of the aryl hydrocarbon receptor. Drug Metab. Dispos., 2003, 31(11), 1279-82. (Pubitemid 37310311)
79. Shin, S. M.; Cho, I. J.; Kim, S. G. CCAAT/enhancer binding protein activation by PD98059 contributes to the inhibition of AhRmediated 3-methylcholanthrene induction of CYP1A1. Xenobiotica, 2005, 35(10-11), 975-87. (Pubitemid 43068042)
80. Murray, I. A.; Flaveny, C. A.; DiNatale, B. C.; Chairo, C. R.; Schroeder, J. C.; Kusnadi, A.; Perdew, G. H. Antagonism of aryl hydrocarbon receptor signaling by 6,2',4'-trimethoxyflavone. J. Pharmacol. Exp. Ther., 2010, 332(1), 135-44.
81. Lu, Y. F.; Santostefano, M.; Cunningham, B. D.; Threadgill, M. D.; Safe, S. Identification of 3'-methoxy-4'-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells. Arch. Biochem. Biophys., 1995, 316(1), 470-7.
82. Zhao, B.; Degroot, D. E.; Hayashi, A.; He, G.; Denison, M. S. CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor. Toxicol. Sci., 2010, 117(2), 393-403.
83. Henry, E. C.; Gasiewicz, T. A. Molecular determinants of speciesspecific agonist and antagonist activity of a substituted flavone towards the aryl hydrocarbon receptor. Arch. Biochem. Biophys., 2008, 472(2), 77-88.
84. Westerink, W. M.; Stevenson, J. C.; Schoonen, W. G. Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition. Arch. Toxicol., 2008, 82(12), 909-21.
85. Sinal, C. J.; Webb, C. D.; Bend, J. R. Differential in vivo effects of alpha-naphthoflavone and beta-naphthoflavone on CYP1A1 and CYP2E1 in rat liver, lung, heart, and kidney. J. Biochem. Mol. Toxicol., 1999, 13(1), 29-40. (Pubitemid 129709401)
86. Merchant, M.; Safe, S. In vitro inhibition of 2,3,7,8-tetrachlorodibenzo- p-dioxin-induced activity by alpha-naphthoflavone and 6- methyl-1,3,8- trichlorodibenzofuran using an aryl hydrocarbon (Ah)-responsive construct. Biochem. Pharmacol., 1995, 50(5), 663-8.
87. Merchant, M.; Morrison, V.; Santostefano, M.; Safe, S. Mechanism of action of aryl hydrocarbon receptor antagonists: Inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression. Arch. Biochem. Biophys., 1992, 298(2), 389-94.
88. Santostefano, M.; Merchant, M.; Arellano, L.; Morrison, V.; Denison, M. S.; Safe, S. alpha-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation. Mol. Pharmacol., 1993, 43(2), 200-6. (Pubitemid 23055063)
89. Lu, Y. F.; Santostefano, M.; Cunningham, B. D.; Threadgill, M. D.; Safe, S. Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists. Biochem. Pharmacol., 1996, 51(8), 1077-87. (Pubitemid 26104628)
90. Kim, S. H.; Henry, E. C.; Kim, D. K.; Kim, Y. H.; Shin, K. J.; Han, M. S.; Lee, T. G.; Kang, J. K.; Gasiewicz, T. A.; Ryu, S. H.; Suh, P. G. Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2- methyl-4-o-tolylazo-phenyl)- amide (CH-223191) prevents 2,3,7,8- TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol. Pharmacol., 2006, 69(6), 1871-8. (Pubitemid 43894303)
91. Murray, I. A.; Krishnegowda, G.; DiNatale, B. C.; Flaveny, C.; Chiaro, C.; Lin, J. M.; Sharma, A. K.; Amin, S.; Perdew, G. H. Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties. Chem. Res. Toxicol., 2010, 23(5), 955-66.
92. Lawrence, B. P.; Denison, M. S.; Novak, H.; Vorderstrasse, B. A.; Harrer, N.; Neruda, W.; Reichel, C.; Woisetschlager, M. Activation of the aryl hydrocarbon receptor is essential for mediating the antiinflammatory effects of a novel low-molecular-weight compound. Blood, 2008, 112(4), 1158-65.
93. Morales, J. L.; Krzeminski, J.; Amin, S.; Perdew, G. H. Characterization of the antiallergic drugs 3- [2-(2-phenylethyl) benzoimidazole- 4-yl]-3-hydroxypropanoic acid and ethyl 3-hydroxy-3- [2-(2- phenylethyl) benzoimidazol-4-yl]propanoate as full aryl hydrocarbon receptor agonists. Chem. Res. Toxicol., 2008, 21(2), 472-82.
94. Negishi, T.; Kato, Y.; Ooneda, O.; Mimura, J.; Takada, T.; Mochizuki, H.; Yamamoto, M.; Fujii-Kuriyama, Y.; Furusako, S. Effects of aryl hydrocarbon receptor signaling on the modulation of TH1/TH2 balance. J. Immunol., 2005, 175(11), 7348-56. (Pubitemid 41713431)
95. DuSell, C. D.; Nelson, E. R.; Wittmann, B. M.; Fretz, J. A.; Kazmin, D.; Thomas, R. S.; Pike, J. W.; McDonnell, D. P. Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators. Mol. Endocrinol., 24(1), 33-46.
96. Fretland, A. J.; Safe, S.; Hankinson, O. Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6- MCDF) in the mouse hepatoma cell line Hepa-1c1c7. Chem. Biol. Interact., 2004, 150(2), 161-70. (Pubitemid 39463279)
97. Weichenthal, S.; Moase, C.; Chan, P. A review of pesticide exposure and cancer incidence in the Agricultural Health Study cohort. Environ. Health Perspect., 2010, 118(8), 1117-25.
98. Cohen, M. Environmental toxins and health-the health impact of pesticides. Aust. Fam. Physician, 2007, 36(12), 1002-4.
99. Takeuchi, S.; Iida, M.; Yabushita, H.; Matsuda, T.; Kojima, H. In vitro screening for aryl hydrocarbon receptor agonistic activity in 200 pesticides using a highly sensitive reporter cell line, DREcoScreen cells, and in vivo mouse liver cytochrome P450-1A in duction by propanil, diuron and linuron. Chemosphere, 2008, 74(1), 155-65.
100. Long, M.; Laier, P.; Vinggaard, A. M.; Andersen, H. R.; Lynggaard, J.; Bonefeld-Jorgensen, E. C. Effects of currently used pesticides in the AhR-CALUX assay: Comparison between the human TV101L and the rat H4IIE cell line. Toxicology, 2003, 194(1-2), 77-93. (Pubitemid 37421384)
101. Schoket, B.; Vincze, I. Dose-related induction of rat hepatic drugmetabolizing enzymes by diuron and chlorotoluron, two substituted phenylurea herbicides. Toxicol. Lett., 1990, 50(1), 1-7. (Pubitemid 20034703)
102. Denison, M. S.; Phelan, D.; Winter, G. M.; Ziccardi, M. H. Carbaryl, a carbamate insecticide, is a ligand for the hepatic Ah (dioxin) receptor. Toxicol. Appl. Pharmacol., 1998, 152(2), 406-14. (Pubitemid 28492282)
103. Ciolino, H. P.; Daschner, P. J.; Yeh, G. C. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J., 1999, 340 (Pt 3), 715-22. (Pubitemid 29312869)
104. Zhang, S.; Qin, C.; Safe, S. H. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: Effects of structure and cell context. Environ. Health. Perspect., 2003, 111(16), 1877-82. (Pubitemid 37541197)
105. Bohonowych, J. E.; Zhao, B.; Timme-Laragy, A.; Jung, D.; Di Giulio, R. T.; Denison, M. S. Newspapers and newspaper ink contain agonists for the ah receptor. Toxicol. Sci., 2008, 102(2), 278-90. (Pubitemid 351404899)
106. Seidel, S. D.; Li, V.; Winter, G. M.; Rogers, W. J.; Martinez, E. I.; Denison, M. S. Ah receptor-based chemical screening bioassays: Application and limitations for the detection of Ah receptor agonists. Toxicol. Sci., 2000, 55(1), 107-15. (Pubitemid 30252441)
107. Binderup, M. L.; Pedersen, G. A.; Vinggaard, A. M.; Rasmussen, E. S.; Rosenquist, H.; Cederberg, T. Toxicity testing and chemical analyses of recycled fibre-based paper for food contact. Food Addit. Contam., 2002, 19 Suppl, 13-28. (Pubitemid 34308730)
108. Mustafa, M. G. Biochemical basis of ozone toxicity. Free Radic. Biol. Med., 1990, 9(3), 245-65.
109. Bell, M. L.; McDermott, A.; Zeger, S. L.; Samet, J. M.; Dominici, F. Ozone and short-term mortality in 95 US urban communities. 1987-2000, JAMA, 2004, 292(19), 2372-8. (Pubitemid 39491922)
110. Valacchi, G.; van der Vliet, A.; Schock, B. C.; Okamoto, T.; Obermuller-Jevic, U.; Cross, C. E.; Packer, L. Ozone exposure activates oxidative stress responses in murine skin. Toxicology, 2002, 179(1-2), 163-70. (Pubitemid 35245472)
111. Afaq, F.; Zaid, M. A.; Pelle, E.; Khan, N.; Syed, D. N.; Matsui, M. S.; Maes, D.; Mukhtar, H. Aryl hydrocarbon receptor is an ozone sensor in human skin. J. Invest. Dermatol., 2009, 129(10), 2396-403.
112. Ashida, H.; Fukuda, I.; Yamashita, T.; Kanazawa, K. Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS. Lett., 2000, 476(3), 213-7. (Pubitemid 30410820)
113. Gradelet, S.; Astorg, P.; Pineau, T.; Canivenc, M. C.; Siess, M. H.; Leclerc, J.; Lesca, P. Ah receptor-dependent CYP1A induction by two carotenoids, canthaxanthin and beta-apo-8'-carotenal, with no affinity for the TCDD binding site. Biochem. Pharmacol., 1997, 54(2), 307-15. (Pubitemid 27357008)
114. Vrzal, R.; Zdarilova, A.; Ulrichova, J.; Blaha, L.; Giesy, J. P.; Dvorak, Z. Activation of the aryl hydrocarbon receptor by berberine in HepG2 and H4IIE cells: Biphasic effect on CYP1A1. Biochem. Pharmacol. 2005, 70(6), 925-36. (Pubitemid 41138858)
115. Ciolino, H. P.; Daschner, P. J.; Wang, T. T.; Yeh, G. C. Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem. Pharmacol., 1998, 56(2), 197-206. (Pubitemid 28479827)
116. Ciolino, H. P.; Wang, T. T.; Yeh, G. C. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res., 1998, 58(13), 2754-60. (Pubitemid 28311904)
117. Allen, S. W.; Mueller, L.; Williams, S. N.; Quattrochi, L. C.; Raucy, J. The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human cyp1a1 expression. Drug Metab. Dispos., 2001, 29(8), 1074-9. (Pubitemid 32660523)
118. Yannai, S.; Day, A. J.; Williamson, G.; Rhodes, M. J. Characterization of flavonoids as monofunctional or bifunctional inducers of quinone reductase in murine hepatoma cell lines. Food Chem. Toxicol., 1998, 36(8), 623-30. (Pubitemid 28369889)
119. Amakura, Y.; Tsutsumi, T.; Sasaki, K.; Nakamura, M.; Yoshida, T.; Maitani, T. Influence of food polyphenols on aryl hydrocarbon receptor-signaling pathway estimated by in vitro bioassay. Phytochemistry, 2008, 69(18), 3117-30.
120. Van der Heiden, E.; Bechoux, N.; Muller, M.; Sergent, T.; Schneider, Y. J.; Larondelle, Y.; Maghuin-Rogister, G.; Scippo, M. L. Food flavonoid aryl hydrocarbon receptor-mediated agonistic/ antagonistic/synergic activities in human and rat reporter gene assays. Anal. Chim. Acta., 2009, 637(1-2), 337-45.
121. Amakura, Y.; Tsutsumi, T.; Nakamura, M.; Kitagawa, H.; Fujino, J.; Sasaki, K.; Toyoda, M.; Yoshida, T.; Maitani, T. Activation of the aryl hydrocarbon receptor by some vegetable constituents determined using in vitro reporter gene assay. Biol. Pharm. Bull., 2003, 26(4), 532-9. (Pubitemid 40003752)
122. Palermo, C. M.; Hernando, J. I.; Dertinger, S. D.; Kende, A. S.; Gasiewicz, T. A. Identification of potential aryl hydrocarbon receptor antagonists in green tea. Chem. Res. Toxicol., 2003, 16(7), 865-72. (Pubitemid 36899001)
123. Graham, H. N. Green tea composition, consumption, and polyphenol chemistry. Prev. Med., 1992, 21(3), 334-50.
124. Williams, S. N.; Shih, H.; Guenette, D. K.; Brackney, W.; Denison, M. S.; Pickwell, G. V.; Quattrochi, L. C. Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression. Chem. Biol. Interact., 2000, 128(3), 211-29.
125. Palermo, C. M.; Westlake, C. A.; Gasiewicz, T. A. Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. Biochemistry, 2005, 44(13), 5041-52. (Pubitemid 40471220)
126. Yin, Z.; Henry, E. C.; Gasiewicz, T. A. (-)-Epigallocatechin-3- gallate is a novel Hsp90 inhibitor. Biochemistry, 2009, 48(2), 336-45.
127. Natsume, M.; Osakabe, N.; Yamagishi, M.; Takizawa, T.; Nakamura, T.; Miyatake, H.; Hatano, T.; Yoshida, T. Analyses of polyphenols in cacao liquor, cocoa, and chocolate by normal-phase and reversed-phase HPLC. Biosci. Biotechnol. Biochem., 2000, 64(12), 2581-7.
128. Mukai, R.; Fukuda, I.; Nishiumi, S.; Natsume, M.; Osakabe, N.; Yoshida, K.; Ashida, H. Cacao polyphenol extract suppresses transformation of an aryl hydrocarbon receptor in C57BL/6 mice. J. Agric. Food Chem., 2008, 56(21), 10399-405.
129. Fukuda, I.; Sakane, I.; Yabushita, Y.; Kodoi, R.; Nishiumi, S.; Kakuda, T.; Sawamura, S.; Kanazawa, K.; Ashida, H. Pigments in green tea leaves (Camellia sinensis) suppress transformation of the aryl hydrocarbon receptor induced by dioxin. J. Agric. Food Chem., 2004, 52(9), 2499-506.
130. Park, Y. K.; Fukuda, I.; Ashida, H.; Nishiumi, S.; Guzman, J. P.; Sato, H. H.; Pastore, G. M. Suppression of dioxin mediated aryl hydrocarbon receptor transformation by ethanolic extracts of propolis. Biosci. Biotechnol. Biochem., 2004, 68(4), 935-8. (Pubitemid 39251468)
131. Nishiumi, S.; Yabushita, Y.; Fukuda, I.; Mukai, R.; Yoshida, K.; Ashida, H. Molokhia (Corchorus olitorius L.) extract suppresses transformation of the aryl hydrocarbon receptor induced by dioxins. Food Chem. Toxicol., 2006, 44(2), 250-60. (Pubitemid 41773820)
132. Casper, R. F.; Quesne, M.; Rogers, I. M.; Shirota, T.; Jolivet, A.; Milgrom, E.; Savouret, J. F. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity. Mol. Pharmacol., 1999, 56(4), 784-90. (Pubitemid 29491181)
133. Ciolino, H. P.; Daschner, P. J.; Yeh, G. C. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res., 1998, 58(24), 5707-12. (Pubitemid 29006410)
134. Revel, A.; Raanani, H.; Younglai, E.; Xu, J.; Rogers, I.; Han, R.; Savouret, J. F.; Casper, R. F. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo [a]pyrene. J. Appl. Toxicol., 2003, 23(4), 255-61. (Pubitemid 36950295)
135. Lu, C. C.; Chen, J. K. Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways. J. Cell Physiol., 2010, 223(2), 343-51.
136. de Medina, P.; Casper, R.; Savouret, J. F.; Poirot, M. Synthesis and biological properties of new stilbene derivatives of resveratrol as new selective aryl hydrocarbon modulators. J. Med. Chem., 2005, 48(1), 287-91. (Pubitemid 40105267)
137. Choi, H.; Chun, Y. S.; Shin, Y. J.; Ye, S. K.; Kim, M. S.; Park, J. W. Curcumin attenuates cytochrome P450 induction in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin by ROS-dependently degrading AhR and ARNT. Cancer Sci., 2008, 99(12), 2518-24.
138. Singh, S. V.; Hu, X.; Srivastava, S. K.; Singh, M.; Xia, H.; Orchard, J. L.; Zaren, H. A. Mechanism of inhibition of benzo [a]pyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogenesis, 1998, 19(8), 1357-60. (Pubitemid 28409831)
139. Garg, R.; Gupta, S.; Maru, G. B. Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo [a]pyrene-treated mice: Mechanism of its anti-initiating action. Carcinogenesis, 2008, 29(5), 1022-32. (Pubitemid 351982248)
140. Nishiumi, S.; Yoshida, K.; Ashida, H. Curcumin suppresses the transformation of an aryl hydrocarbon receptor through its phosphorylation. Arch. Biochem. Biophys., 2007, 466(2), 267-73. (Pubitemid 47451352)
141. El Gendy, M. A.; El-Kadi, A. O. Harman induces CYP1A1 enzyme through an aryl hydrocarbon receptor mechanism. Toxicol. Appl. Pharmacol., 2010, 249(1), 55-64.
142. Louis, E. D.; Pellegrino, K. M.; Factor-Litvak, P.; Rios, E.; Jiang, W.; Henchcliffe, C.; Zheng, W. Cancer and blood concentrations of the comutagen harmane in essential tremor. Mov. Disord., 2008, 23(12), 1747-51.
143. Pfau, W.; Skog, K. Exposure to beta-carbolines norharman and Harman. J. Chromatogr. B. Analyt. Technol .Biomed. Life. Sci., 2004, 802(1), 115-26.
144. Herraiz, T. Relative exposure to beta-carbolines norharman and harman from foods and tobacco smoke. Food Addit. Contam., 2004, 21(11), 1041-50. (Pubitemid 40100683)
145. Haarmann-Stemmann, T.; Sendker, J.; Gotz, C.; Krug, N.; Bothe, H.; Fritsche, E.; Proksch, P.; Abel, J. Regulation of dioxin receptor function by different beta-carboline alkaloids. Arch. Toxicol., 2010, 84(8), 619-29.
146. Han, E. H.; Kim, H. G.; Im, J. H.; Jeong, T. C.; Jeong, H. G. Upregulation of CYP1A1 by rutaecarpine is dependent on aryl hydrocarbon receptor and calcium. Toxicology, 2009, 266(1-3), 38-47.
147. Zhou, H.; Mineshita, S. The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. J. Pharmacol. Exp. Ther., 2000, 294(3), 822-9. (Pubitemid 30666829)
148. Adachi, J.; Mori, Y.; Matsui, S.; Takigami, H.; Fujino, J.; Kitagawa, H.; Miller, C. A., 3rd; Kato, T.; Saeki, K.; Matsuda, T. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem., 2001, 276(34), 31475-8.
149. Nishiumi, S.; Yamamoto, N.; Kodoi, R.; Fukuda, I.; Yoshida, K.; Ashida, H. Antagonistic and agonistic effects of indigoids on the transformation of an aryl hydrocarbon receptor. Arch. Biochem. Biophys., 2008, 470(2), 187-99.
150. Peter Guengerich, F.; Martin, M. V.; McCormick, W. A.; Nguyen, L. P.; Glover, E.; Bradfield, C. A. Aryl hydrocarbon receptor response to indigoids in vitro and in vivo. Arch. Biochem. Biophys., 2004, 423(2), 309-16. (Pubitemid 38328440)
151. Sinal, C. J.; Bend, J. R. Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells. Mol. Pharmacol., 1997, 52(4), 590-9. (Pubitemid 27443980)
152. Phelan, D.; Winter, G. M.; Rogers, W. J.; Lam, J. C.; Denison, M. S. Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch. Biochem. Biophys., 1998, 357(1), 155-63. (Pubitemid 28402597)
153. Schaldach, C. M.; Riby, J.; Bjeldanes, L. F. Lipoxin A4: A new class of ligand for the Ah receptor. Biochemistry, 1999, 38(23), 7594-600.
154. Heath-Pagliuso, S.; Rogers, W. J.; Tullis, K.; Seidel, S. D.; Cenijn, P. H.; Brouwer, A.; Denison, M. S. Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry, 1998, 37(33), 11508-15. (Pubitemid 28388192)
155. Miller, C. A., 3rd. Expression of the human aryl hydrocarbon receptor complex in yeast. Activation of transcription by indole compounds. J. Biol. Chem., 1997, 272(52), 32824-9. (Pubitemid 28023617)
156. Wei, Y. D.; Helleberg, H.; Rannug, U.; Rannug, A. Rapid and transient induction of CYP1A1 gene expression in human cells by the tryptophan photoproduct 6-formylindolo [3,2-b]carbazole. Chem. Biol. Interact., 1998, 110(1-2), 39-55. (Pubitemid 28157363)
157. Katiyar, S. K.; Matsui, M. S.; Mukhtar, H. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J. Invest. Dermatol., 2000, 114(2), 328-33.
158. Fritsche, E.; Schafer, C.; Calles, C.; Bernsmann, T.; Bernshausen, T.; Wurm, M.; Hubenthal, U.; Cline, J. E.; Hajimiragha, H.; Schroeder, P.; Klotz, L. O.; Rannug, A.; Furst, P.; Hanenberg, H.; Abel, J.; Krutmann, J. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc. Natl. Acad. Sci. U S A, 2007, 104(21), 8851-6. (Pubitemid 47175400)
159. Diani-Moore, S.; Labitzke, E.; Brown, R.; Garvin, A.; Wong, L.; Rifkind, A. B. Sunlight generates multiple tryptophan photoproducts eliciting high efficacy CYP1A induction in chick hepatocytes and in vivo. Toxicol. Sci., 2006, 90(1), 96-110. (Pubitemid 43264730)
160. Dvorak, Z.; Vrzal, R.; Ulrichova, J. Silybin and dehydrosilybin inhibit cytochrome P450 1A1 catalytic activity: A study in human keratinocytes and human hepatoma cells. Cell Biol. Toxicol., 2006, 22(2), 81-90. (Pubitemid 43376192)
161. Song, J.; Clagett-Dame, M.; Peterson, R. E.; Hahn, M. E.; Westler, W. M.; Sicinski, R. R.; DeLuca, H. F. A ligand for the aryl hydrocarbon receptor isolated from lung. Proc. Natl. Acad. Sci. U S A, 2002, 99(23), 14694-9. (Pubitemid 35334546)
162. Henry, E. C.; Bemis, J. C.; Henry, O.; Kende, A. S.; Gasiewicz, T. A. A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo. Arch. Biochem. Biophys., 2006, 450(1), 67-77. (Pubitemid 43782737)
163. Henry, E. C.; Welle, S. L.; Gasiewicz, T. A. TCDD and a putative endogenous AhR ligand, ITE, elicit the same immediate changes in gene expression in mouse lung fibroblasts. Toxicol. Sci., 2010, 114(1), 90-100.
164. DiNatale, B. C.; Murray, I. A.; Schroeder, J. C.; Flaveny, C. A.; Lahoti, T. S.; Laurenzana, E. M.; Omiecinski, C. J.; Perdew, G. H. Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol. Sci., 2010, 115(1), 89-97.
165. Kuc, D.; Zgrajka, W.; Parada-Turska, J.; Urbanik-Sypniewska, T.; Turski, W. A. Micromolar concentration of kynurenic acid in rat small intestine. Amino Acids, 2008, 35(2), 503-5.
166. Paluszkiewicz, P.; Zgrajka, W.; Saran, T.; Schabowski, J.; Piedra, J. L.; Fedkiv, O.; Rengman, S.; Pierzynowski, S. G.; Turski, W. A. High concentration of kynurenic acid in bile and pancreatic juice. Amino Acids, 2009, 37(4), 637-41.
167. Jinno, A.; Maruyama, Y.; Ishizuka, M.; Kazusaka, A.; Nakamura, A.; Fujita, S. Induction of cytochrome P450-1A by the equine estrogen equilenin, a new endogenous aryl hydrocarbon receptor ligand, J. Steroid Biochem. Mol. Biol., 2006, 98(1), 48-55. (Pubitemid 43113244)